Developing a Small Molecule for Duchenne Muscular Dystrophy with Frank Gleeson | VibeCast Episode 48

In this episode, VibeCast host Ray Dogum speaks with Frank Gleeson, Co-Founder and CEO of Satellos Bioscience, about groundbreaking small molecule therapies for Duchenne muscular dystrophy.

The key moments in this episode are:
00:00:05 – Introducing Satellos Bioscience
00:03:26 – Stem Cells and Duchenne Muscular Dystrophy
00:09:15 – Potential Treatment for Duchenne Muscular Dystrophy
00:13:22 – Research Discovery and Company Formation
00:15:59 – Clinical Trial Planning and Future Development
00:17:33 – Company Inflection Points
00:19:08 – Drug Impact and Potential
00:20:10 – Potential Indications
00:22:38 – Funding and Financial Strategy
00:24:35 – Biotech Ecosystem and Growth

Check out the full video interview here.